It’s extremely rewarding to work in one of the largest and most diverse global business sectors helping support clients to realize their goals.
Matthew provides mergers and acquisitions (M&A) advisory services and leads Lincoln’s U.K. strategic efforts within the healthcare sector. Matthew has nearly 20 years of M&A advisory experience, executing both sell-side and buy-side transactions for private equity clients, publicly traded companies and privately held and family-owned businesses. His experience spans both U.K. and international markets.
Matthew specializes in advising healthcare services and medical device companies and has a comprehensive understanding of these diverse markets. Matthew delivers on clients’ ambitions by providing hands-on, independent advice and leveraging the global Lincoln healthcare network.
Prior to joining Lincoln, Matthew worked at one of the “Big 4” accountancy firms as a senior member of its healthcare M&A team. Beforehand, Matthew was a private equity investor at Lloyds Development Capital and practiced healthcare M&A at Rothschild & Co in London.
Matthew earned a Bachelor of Science from the University of Bath and holds a Securities Institute Diploma.
Lincoln International represents Sovereign Capital Partners in its sale of Linnaeus Group to Mars Inc.
Lincoln International represents RIG Healthcare in its sale to Cpl Resources plc
Lincoln International advises the private equity investors Granville and Baird Capital in the sale of Amoena Group to Halder
Lincoln International represents Altaris Capital Partners in the sale of Penlon Ltd. to Goldman Sachs backed BPL Medical Technologies Private Ltd.
Perspectives featuring Matthew Lee
Cross-Border Deals: The Right Prescription for Animal Health
As the humanization of pets continues and pet lifespans grow longer, investment opportunities in animal health abound. While most animal health companies will first look for growth within their own… Read More
The Pharmaceutical Journal | Is Amazon Really a Threat to the UK Pharmacy Market?
Matthew Lee, Managing Director at Lincoln International joins the Pharmaceutical Journal deputy news editor, Carolyn Wickware, in a recent episode of The PJ Pod to share his thoughts on the… Read More
Animal Health in the UK: Insights from the LaingBuisson Investing in Healthcare Conference
Pet ownership in the UK increased during the pandemic as animals provided comfort and companionship that individuals lacked during lockdown. Matthew Lee, Managing Director at Lincoln International, joined other industry… Read More
Webinar: Investing in Europe – Q&A on Executing and Financing Deals Post-COVID-19 – Part II
Lincoln International hosted a virtual panel on January 28, 2021 featuring the firm’s experts from across Europe for a Q&A on some of the key considerations and opportunities for investors… Read More